Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
Abstract Background The types of outcomes measured collected in clinical studies and those required for cost-effectiveness analysis often differ. Decision makers routinely use quality adjusted life years (QALYs) to compare the benefits and costs of treatments across different diseases and treatments...
Main Authors: | Laura A. Gray, Monica Hernandez Alava, Allan J. Wailoo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-11-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08964-5 |
Similar Items
-
Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients
by: Kim Seon Ha, et al.
Published: (2012-12-01) -
Mapping the EORTC QLQ-C30 onto the EQ-5D-5L index for patients with paroxysmal nocturnal hemoglobinuria in France
by: Piotr Wojciechowski, et al.
Published: (2023-04-01) -
Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model
by: Mira D. Franken, et al.
Published: (2020-07-01) -
Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer
by: Yasuhiro Hagiwara, et al.
Published: (2020-11-01) -
Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer
by: Siobhan Bourke, et al.
Published: (2024-09-01)